University Clinic Heidelberg Explores Advanced TomoTherapy® Delivery Technique

MADISON, Wis.--(EON: Enhanced Online News)--TomoTherapy Incorporated (NASDAQ: TOMO) announced today that research partner University Clinic Heidelberg, Germany, has demonstrated the ability to dramatically reduce treatment times for the TomoTherapy® Hi·Art® system, while at the same time improving plan quality by further reducing radiation dose to normal tissue. Based on an in-depth planning study, University Clinic Heidelberg researchers anticipate that a reduction in treatment time of between 40 to 75 percent will be possible with next-generation delivery techniques currently in development by TomoTherapy. Detailed findings of the study will be published later this year.

University Clinic Heidelberg, one of the top radiation oncology institutes worldwide, installed the Hi·Art treatment system in March 2006. In December 2008, the medical team, led by Prof. Dr. Jürgen Debus, Prof. Dr. Klaus Herfarth and Dr. Florian Sterzing, treated its 500th cancer patient with TomoTherapy’s unique CT platform-based solution for image-guided, intensity-modulated radiation therapy (IG-IMRT).

source: TomoTherapy